News
Evotec slashes staff as turnaround plan gathers pace
Evotec has announced the next phase of its company overhaul, dubbed Horizon, that will see 800 people lose their jobs in a bid to cut €75m in costs.
R&D
How medical supply chains are adapting to global disruptions
From the lingering impacts of pandemic-era bottlenecks to geopolitical tensions and extreme weather events, medical supply chains are under pressure.
News
Vertex preps FDA filing for IgAN drug after phase 3 readout
Vertex's bid to expand beyond cystic fibrosis has taken a big step forward with phase 3 data for povetacicept in severe kidney disorder IgAN.
R&D
Treating genetic disease at scale with tRNA, with Michelle W...
Michelle Werner, Director of Alltrna, discusses her company’s approach of leveraging transfer RNA (tRNA) to shift the paradigm in genetic medicine.
News
BioNTech bigwigs will step down to form new mRNA company
The co-founders of mRNA specialist BioNTech – husband and wife team Uğur Şahin and Özlem Türeci – have said they are leaving to set up a new company.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
